Glycine is a simple amino acid with an established place in Japan’s “before bed” supplement category, usually as a plain powder stick taken shortly before sleep. Brands abroad ask for it because the Japanese research and product format are distinctive, and the ingredient itself is inexpensive and easy to formulate.
This guide is for brand owners planning an oral glycine product made in Japan. It covers what the human trials show, how small and concentrated that evidence base is, how Japan frames the ingredient, and how to formulate a glycine powder or stick.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a glycine product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
A handful of small Japanese trials, taking around 3 g of glycine before bed, report better subjective sleep quality and next-day alertness, but the evidence base is tiny and largely produced by researchers affiliated with a single ingredient manufacturer.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| Randomised, double-blind, cross-over trial, Sleep and Biological Rhythms 2006 (DOI 10.1111/j.1479-8425.2006.00193.x) | People with sleep-quality complaints took 3 g of glycine or placebo before bedtime, assessed the next morning with standard sleep and fatigue questionnaires | Glycine significantly improved next-morning fatigue, liveliness/peppiness and clear-headedness scores versus placebo |
| Randomised, single-blind, cross-over trial, Frontiers in Neurology 2012 (PMC3328957, PMID 22529837, DOI 10.3389/fneur.2012.00061) | 10 healthy male volunteers enrolled (7 analysed) had sleep restricted to 25% below their normal amount for 3 nights and took 3 g of glycine or placebo 30 minutes before bed | Glycine significantly reduced next-day fatigue on day 1 (p=0.022) and improved psychomotor vigilance reaction time on days 1 and 3; sleepiness trended toward improvement but did not reach significance |
Caveats worth knowing:
- Very small samples. The 2012 trial enrolled 10 people and analysed only 7, and neither study is large enough to generalise from with confidence.
- Author affiliation. The 2012 trial’s authors were affiliated with a major glycine producer or a university research partner, and the volunteers were the company’s employees, though the paper states the authors declared no competing interests and that the study was supported in part by a public research programme.
- Subjective outcomes dominate. Most of what improved was self-reported fatigue and alertness rather than objective sleep-architecture measures across the whole evidence base.
- Short duration. Both studies covered only a few nights of use, not sustained daily use over weeks or months.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
Glycine has been notified under Japan’s Foods with Function Claims system, often alongside GABA in the same product, for functions describing a good night’s sleep, feeling refreshed on waking, and easing next-day sleepiness and fatigue.
Under this system, the business that notifies the product is responsible for its own evidence, submitted to the Consumer Affairs Agency before sale. The Japanese “before bed” category most commonly combines glycine with GABA in a single powder stick, rather than selling glycine alone — worth noting if you want a single-ingredient claim rather than a combination product.
Two lessons for a brand abroad:
- The Japanese wording stays modest. It describes everyday sleep depth and next-day refreshment, not a cure for a sleep disorder.
- A Japanese notification is a domestic mechanism. It applies to products sold in Japan. Your label abroad follows your own market’s rules.
💬 Need an evidence summary for your regulatory adviser that separates Japanese notifications from independent trials? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe glycine by the amount studied and the subjective outcome measured, not by any sleep disorder.
| Safer wording | Wording to avoid |
|---|---|
| ”Contains 3 g glycine, the amount studied before bed” | Names of sleep disorders, or “cures insomnia" |
| "Studied for next-morning alertness and sleep quality" | "Clinically proven” without naming the study, its size and its limits |
| Noting that the evidence base is small | Presenting a handful of small trials as settled science |
How glycine is formulated
The studied amount is a full 3 grams, which is too much for a small tablet, so Japan sells glycine almost entirely as a powder stick or granule dissolved before bed.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Powder stick or sachet | Fits the 3 g gram-level dose in a single-serve format | Taste — glycine has a mildly sweet flavour that some brands use as an advantage |
| Granule in a tub | Lower packaging cost per serving than sachets | Consistent dosing by the consumer |
| Drink | Pre-dissolved evening-routine product | Shelf-life and taste masking at this concentration |
Decisions that shape the specification:
- Amount per serving. 3 g before bed is the amount used in both trials above and in the Japanese “before bed” category; a materially lower amount moves away from the studied dose.
- Companion ingredients. GABA is the most common Japanese pairing. Any companion, herbal or otherwise, needs its own check against Japanese food law.
- Format. At a gram-level dose, capsules or tablets become impractical; a powder stick, granule or drink is the realistic choice.
- Packaging. Single-serve sachets suit an evening routine and make the daily amount unambiguous to the consumer.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Glycine itself is widely used in Japanese foods. Relaxation and sleep formulas are where companion herbs most often cause a problem. See the Japan-made supplement OEM page, and compare with our GABA and L-theanine guides if you plan a combined product.
Before you ask for a quotation
A factory can quote accurately once the amount, the format and the companions are fixed.
- Glycine amount per serving (commonly 3 g) and servings per pack
- Dosage form — powder stick, granule or drink
- Flavour and any taste-masking needed
- Companion ingredients and their amounts
- Packaging
- Countries you will sell in, and first order and annual volume
💬 Ready to design a Japan-made glycine product? Send us the concept — amount, format, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Does glycine actually improve sleep?
Two small trials at 3 g before bed reported better next-morning fatigue, alertness and subjective sleep ratings. The evidence base is tiny, so describe it as studied in small trials, not as a proven sleep fix.
2. Why is 3 g the standard amount?
It is the dose used in both cited trials and in Japan’s “before bed” product category. A materially lower amount would not match the studied dose.
3. Is the research independent of industry?
Not entirely. One trial’s authors were affiliated with a major glycine manufacturer, and its volunteers were company employees, though the paper discloses no competing interests and cites partial public research support. We state this rather than hide it.
4. Why is glycine sold as a powder, not a capsule?
The studied amount is a full 3 grams — too much to fit comfortably in a swallowable capsule, so a powder stick, granule or drink is the practical format.
5. Can I combine glycine with GABA?
Yes — it is the most common Japanese pairing in this category. Any companion ingredient needs its own check against Japanese food law before it goes into the formula.
Sources: “Subjective effects of glycine ingestion before bedtime on sleep quality”, Inagawa et al., Sleep and Biological Rhythms 2006 (DOI 10.1111/j.1479-8425.2006.00193.x); “The Effects of Glycine on Subjective Daytime Performance in Partially Sleep-Restricted Healthy Volunteers”, Bannai & Kawai et al., Frontiers in Neurology 2012 (PMC3328957, PMID 22529837, DOI 10.3389/fneur.2012.00061); Consumer Affairs Agency notifications for Foods with Function Claims. Checked on 25 September 2026.